Lupus kidney drug tested in kids – but study stopped early
NCT ID NCT05962788
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at the long-term safety of the drug voclosporin in adolescents and children with lupus nephritis, a kidney disease caused by lupus. Participants took voclosporin capsules twice daily along with standard medications. The trial was terminated early and only enrolled 4 people, so the results are very limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- voclosporin
- What this could lead to
- If successful, this could show that voclosporin is safe and effective for long-term use in young people with lupus nephritis.
- What could go wrong
- The trial was terminated early and enrolled only 4 participants, so results are very limited. It is unclear if voclosporin offers benefits over standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADOLESCENT LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro de Especialidades Medicas del Sureste
Mérida, Yucatán, 97000, Mexico
-
Clinica de la Costa S.A.S
Barranquilla, Atlántico, 76100, Colombia
-
Hospital Infantil de México Federico Gómez
Mexico City, 06720, Mexico
-
Siriraj Hospital
Bangkok, 10700, Thailand
-
UNC-Chapel Hill
Chapel Hill, North Carolina, 27514, United States
-
Yokohama City University Hospital
Yokohama, Kanagawa, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.